Table III.
Primary hyperparathyroidism patients with chronic pancreatitis vs. acute pancreatitis
| Parameters | PHPT-AP (n=18), n (%) | PHPT-CP (n=17), n (%) |
|---|---|---|
| Male/female | 10/8 | 8/9 |
| Pancreatic calcification | 0 | 8 (47) |
| Diabetes mellitus | 2 (11) | 5 (29.4) |
| Pain abdomen | 15 (83.3) | 17 (100) |
| Nausea and vomiting | 13 (72.2) | 10 (58.8) |
| Weight loss | 5 (27.8) | 9 (52.9) |
| Bone disease | 8 (44.4) | 1 (5.9)*** |
| Nephrolithiasis | 6 (33.3) | 8 (47) |
| Nephrocalcinosis | 6 (33.3) | 5 (29.4) |
| Cholecystectomy | 2 (11.1) | 6 (35.3) |
| Serum calcium (mg/dl) | 13.13±2.0 | 11.67±1.69* |
| Inorganic phosphate (mg/dl) | 2.87±0.55 | 3.12±1.4# |
| iPTH (pg/ml) | 731.1±680.3 | 280.2±133*,# |
| 25(OH) vitamin D (ng/ml) | 24.7±23.1 | 16.8±12.2# |
| Creatinine (mg/dl) | 0.8±0.4 | 1.1±0.8# |
P *<0.05, ***<0.001, #Mann-Whitney U-test was applied for the analysis. iPTH, intact parathyroid hormone; PHPT-AP, primary hyperparathyroidism patients with acute pancreatitis; PHPT-CP, primary hyperparathyroidism patients with chronic pancreatitis